Head and Neck Cancer News & Features
Patients with oropharyngeal cancer who were found to have detectable traces of human papillomavirus type 16 (HPV16) in their saliva.
A new proof of principle study seems to validate the usefulness of DNA testing to detect cancers in the oral cavity.
Study shows potential for noninvasive tumor detection for head and neck cancer.
The Medicare costs for older patients with oral cavity and pharyngeal cancers have increased due to several factors, including on demographics, treatment selection, and co-existing illnesses.
Certain human papillomavirus (HPV)-16 antibodies in the blood associated with improved survival in HPV-related oropharyngeal carcinoma.
Head and Neck Cancer Clinical Trials
- Certain nutrients may fuel cancer therapy resistance
- Multiple myeloma uses "wolf in sheep's clothing" tactic to avoid immune response in bone
- New approach to treating B-cell acute lymphoblastic leukemia shows promise
- Protein associated with spread of osteosarcoma
- Researchers identify lynchpin molecule for prostate cancer metastasis
- Epigenetic driver of glioblastoma provides new therapeutic target
- Young adult cancer survivors experience increased rate of hospitalization
- Missed diagnostic testing has negative impact on lung cancer treatment
- Veterans returning from Iraq, Afghanistan may have increased risk of skin cancer
- Certain patients with germ cell cancer should receive life-long follow-up
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|